Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma

NCT01968317 is registered in ClinicalTrials.gov with Xiaojun Chen as lead sponsor.

NCT NCT01968317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01968317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
Lead sponsor
Xiaojun Chen
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
October 31, 2017
Enrollment
150 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial adenocarcinoma, endometrial atypical hyperplasia